Cargando…
Development of a new metastatic human breast carcinoma xenograft line.
Xenografts originated from human tumours offer the most appropriate research material for in vivo experimental research. However, primary human breast carcinomas are difficult to grow when transplanted in athymic mice: tumour take is less than 15%. Recently, we have achieved 60% tumour take by injec...
Autores principales: | Mehta, R. R., Graves, J. M., Shilkaitis, A., Das Gupta, T. K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2149914/ https://www.ncbi.nlm.nih.gov/pubmed/9484817 |
Ejemplares similares
-
Suppression of tumorigenic and metastatic potentials of human melanoma cell lines by mutated (143 Val-Ala) p53.
por: Rauth, S., et al.
Publicado: (1998) -
A novel model of a metastatic human breast tumour xenograft line.
por: Hurst, J., et al.
Publicado: (1993) -
Development of drug resistance in a human epidermoid lung carcinoma xenograft line.
por: Mattern, J., et al.
Publicado: (1988) -
Chemotherapy of human breast-carcinoma xenografts.
por: Bailey, M. J., et al.
Publicado: (1980) -
New generation breast cancer cell lines developed from patient-derived xenografts
por: Finlay-Schultz, Jessica, et al.
Publicado: (2020)